A A +A
[wpml_language_selector_widget]

SELAMAT DATANG KE PORTAL RASMI
MYHEALTH KEMENTERIAN KESIHATAN MALAYSIA

  1. Home
  2. /
  3. PRIME YEARS
  4. /
  5. Reproductive Health
  6. /
  7. Risks of Multiple Pregnancies

Risks of Multiple Pregnancies

The infertility treatment’s primary goal has always been for each couple to have one healthy child at a time. However, there are many challenges to this and undoubtedly the most important issue has been multiple pregnancies either twins or more (i.e.: high-order multiple).

In many occasions, fertility drugs for ovarian follicular growth is used to assist in natural conception. It can result in multiple follicle growth especially if it is not monitored therefore resulting in multiple pregnancy. The commonest fertility oral medication is clomiphene citrate while injections are gonadotropins.

In IVF (Assisted Reproductive Technologies) multiple embryos are transferred to increase pregnancy rates. The reasons include infertile couples’ sense of urgency resulting in acceptance of more aggressive management, high cost associated with IVF and competitive pressure among clinicians to maintain high rates.

Worldwide the data on IVF and use of exogenous gonadotropin induced ovulation induction or fertility drugs is limited.  Generally in the US it is felt that majority of twin birth results from natural conception (~60%) with fertility drugs (21–32%) and IVF (8-16%). While in regards to high-order multiple pregnancy around 20% is from natural conception, fertility drugs (39-67%) and IVF (13-44%). Therefore naturally-conceived twins account for the majority of all multiple births, the incidence of twins among births resulting specifically from fertility drugs and IVF is more than 20 times greater than for births resulting from natural conception, and that of high-order multiple gestation is more than 100 times higher.

Complications of multiple pregnancies include increased maternal morbidity as well as both fetal and neonatal morbidity and mortality. The maternal problems include preeclampsia, gestational diabetes, anameia, excess weight gain, hyperemesis gravidarum, preterm labour, as well as increased incidence of low lying placenta, vasa previa, premature separation of placenta and postpartum haemorrhage. While most of the perinatal morbidity and mortality is associated directly to preterm delivery (cerebral palsy, retinopathy and bronchopulmonary dysplasia) and those of fetal growth restriction (polycythemia, hypoglycemia and necrotizing enterocolitis). Furthermore the emotional, physical and financial stresses are increased among these couples. The economic costs also escalate with an increase in medical care cost of four fold and tenfold for twins and triplets respectively.

The strategies that help in overcoming this include educating all concerned on the risks with multiple pregnancies, encouraging single embryo transfers in IVF followed by frozen embryo transfers (maximizing cumulative pregnancy rates) and where permissible multifetal pregnancy reduction.

Risk for babies

Twins

Triplets

Proportion born prematurely with low birthweight

50%

90%

Death in the first week of life

5x higher*

9x higher*

Cerebral palsy

4x higher*

18x higher*

pre-eclampsia (for mothers)

3x higher*

9x higher*

*than for singleton births

Risk for mothers

Twins

Triplets

pre-eclampsia

3x higher*

9x higher*

diabetes

2 – 3x higher*

 

coronary heart disease

2x higher**

 

death from cardiovascular causes

7 – 11x higher***

 

*than for singleton births
**with preterm delivery
***with delivery of low birthweight baby
Source: Sattar N & Greer I BMJ 2002;3255 157-160

References:

  1. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee Opinion. Fertility & Sterility April 2012
  2. Multiple pregnancy associated with infertility therapy. Fertility & Sterility 2006
  3. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertility & Sterility Jan. 2009
Last Reviewed : 31 March 2017
Writer : Dr. Kannappan a/l Palaniappan
Accreditor : Dr. Noraihan bt. Muhd Nordin

 

Artikel Berkaitan

Andropos

Apakah itu Andropos? Andropos juga dikenali sebagai ADAM (Penurunan hormone

ALAMAT

Bahagian Pendidikan Kesihatan,
Kementerian Kesihatan Malaysia,
Aras 1-3, Blok E10, Kompleks E,
Kompleks Pentadbiran Kerajaan Persekutuan,
62590 Putrajaya, Malaysia.

TALIAN AM :   +603 8000 8000

FAKS :   +603 8888 6200

EMEL :   myhealth@moh.gov.my

BILANGAN PENGUNJUNG : 227,772,827

TARIKH AKHIR KEMASINI :
2024-07-16 15:32:21

PAPARAN TERBAIK   Paparan terbaik menggunakan pelayar Google Chrome Version 57.0, Mozilla Firefox Version 52.0 dengan resolusi 1366 x 768px

Hakcipta Terpelihara ©2005-2022 Bahagian Pendidikan Kesihatan, Kementerian Kesihatan Malaysia